View of SGLT2 Inhibitor–associated Bullous Pemphigoid: A Comprehensive Review of Clinical Phenotypes, Latency, Immunopathologic Findings, Proposed Mechanisms, and Clinical Outcomes

Return to Article Details SGLT2 Inhibitor–associated Bullous Pemphigoid: A Comprehensive Review of Clinical Phenotypes, Latency, Immunopathologic Findings, Proposed Mechanisms, and Clinical Outcomes Download PDF